Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-22-024487

President and CEO sold 84,000 shares at an average $31.42 ($2,639,280)

  • President and CEO acquired 84,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patel Sanjiv President and CEO 2022-04-12 Option exercise +28,000 $4.12 $115,360 281,740 D
Patel Sanjiv President and CEO 2022-04-12 Sale −28,000 $31.80 $890,400 253,740 D
Patel Sanjiv President and CEO 2022-04-13 Option exercise +14,000 $4.12 $57,680 267,740 D
Patel Sanjiv President and CEO 2022-04-13 Sale −14,000 $31.96 $447,440 253,740 D
Patel Sanjiv President and CEO 2022-04-13 Option exercise +14,000 $5.04 $70,560 267,740 D
Patel Sanjiv President and CEO 2022-04-13 Sale −14,000 $31.94 $447,160 253,740 D
Patel Sanjiv President and CEO 2022-04-14 Option exercise +14,000 $4.12 $57,680 267,740 D
Patel Sanjiv President and CEO 2022-04-14 Sale −14,000 $30.51 $427,140 253,740 D
Patel Sanjiv President and CEO 2022-04-14 Option exercise +14,000 $5.04 $70,560 267,740 D
Patel Sanjiv President and CEO 2022-04-14 Sale −14,000 $30.51 $427,140 253,740 D
Derivatives
Patel Sanjiv President and CEO 2022-04-12 Option exercise · Stock Option (Right to Buy) −28,000 144,175 D
Patel Sanjiv President and CEO 2022-04-13 Option exercise · Stock Option (Right to Buy) −14,000 130,175 D
Patel Sanjiv President and CEO 2022-04-13 Option exercise · Stock Option (Right to Buy) −14,000 718,604 D
Patel Sanjiv President and CEO 2022-04-14 Option exercise · Stock Option (Right to Buy) −14,000 116,175 D
Patel Sanjiv President and CEO 2022-04-14 Option exercise · Stock Option (Right to Buy) −14,000 704,604 D
Open-market sales · 84,000 sh · avg $31.42 · $2,639,280
Loading xslF345X03/doc4.xml…